The Serum Institute has distanced itself from its government director’s assertion that the Centre started the COVID-19 vaccination of a number of age teams with out considering the obtainable inventory, stating that that is “not the view of the company”.
In a letter to the Union Health Ministry on May 22, Prakash Kumar Singh, Director of Government and Regulatory Affairs on the Pune-based Serum Institute of India (SII), clarified that the assertion by its government director Suresh Jadav at a latest occasion just isn’t the view of the corporate, sources stated.
“On behalf of our CEO Adar C Poonawalla, I want to inform you that this statement is not issued on behalf of SIIPL and the Company completely dissociates itself from this statement. It is reiterated that, this is not the view of the company at all.
“SIIPL is dedicated to maximise its Covishield manufacturing and it stands shoulder to shoulder to strengthen the federal government’s combat towards COVID-19,” he stated in a communique.
SII additionally clarified that Poonawalla is the one official spokesperson of the corporate.
Amid an acute scarcity of COVID-19 vaccines within the nation, SII government director Suresh Jadhav on Friday alleged that the federal government started inoculating individuals from a number of age teams with out bearing in mind the obtainable inventory of vaccines and the WHO pointers.